Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.
Mast TC, Kierstead L, Gupta SB, Nikas AA, Kallas EG, Novitsky V, Mbewe B, Pitisuttithum P, Schechter M, Vardas E, Wolfe ND, Aste-Amezaga M, Casimiro DR, Coplan P, Straus WL, Shiver JW. Mast TC, et al. Among authors: nikas aa. Vaccine. 2010 Jan 22;28(4):950-7. doi: 10.1016/j.vaccine.2009.10.145. Epub 2009 Nov 17. Vaccine. 2010. PMID: 19925902
Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, Vardas E, Schechter M, Kallas EG, Freed DC, Fu TM, Mast CT, Puthavathana P, Kublin J, Brown Collins K, Chisi J, Pendame R, Thaler SJ, Gray G, Mcintyre J, Straus WL, Condra JH, Mehrotra DV, Guess HA, Emini EA, Shiver JW. Coplan PM, et al. J Infect Dis. 2005 May 1;191(9):1427-34. doi: 10.1086/428450. Epub 2005 Mar 30. J Infect Dis. 2005. PMID: 15809900
Post-marketing evaluation of the short term safety of COMVAX.
Davis RL, Black S, Shinefield H, Mahoney L, Zavitkovsky A, Lewis E, Nikas A, Guess H, Coplan P. Davis RL, et al. Vaccine. 2004 Jan 2;22(3-4):536-43. doi: 10.1016/j.vaccine.2003.06.001. Vaccine. 2004. PMID: 14670337
12 results